We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tools
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current RUA market cap is 2.47M. The company's latest EPS is GBP -0.0903 and P/E is -1.23.
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 463k | 489k | 1.53M | 1.63M | 2.18M |
| Operating Income | -653k | -977k | -1.59M | -2.36M | -1.92M |
| Net Income | -609k | -816k | -1.45M | -2.07M | -2M |
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 3.1M | 2.49M | 10.16M | 7.63M | 5.66M |
| Total Liabilities | 99k | 219k | 1.65M | 1.04M | 980k |
| Total Equity | 3M | 2.28M | 8.51M | 6.58M | 4.68M |
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -422k | -438k | -1.41M | -2.35M | -1.15M |
| Investing | -140k | 2k | -952k | -912k | -477k |
| Financing | 2.55M | N/A | 6.68M | -66k | 132k |
| Market Cap | 2.47M |
| Price to Earnings Ratio | -1.23 |
| Price to Sales Ratio | 1.14 |
| Price to Cash Ratio | 1.67 |
| Price to Book Ratio | 0.53 |
| Dividend Yield | - |
| Shares Outstanding | 22.18M |
| Average Volume (1 week) | 1.97M |
| Average Volume (1 Month) | 972.82k |
| 52 Week Change | -66.21% |
| 52 Week High | 67.50 |
| 52 Week Low | 11.00 |
| Spread (Intraday) | 0.3 (2.65%) |
| Company Name | Rua Life Sciences Plc |
| Address |
c/o kergan stewart llp glasgow G2 4SQ |
| Website | https://www.rualifesciences.com |
| Industry | plastics,resins,elastomers (2821) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
